K. C. Chang, W. W. Yew, and Y. Zhang, Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses, Antimicrobial Agents and Chemotherapy, vol.55, issue.10, pp.4499-4505, 2011.
DOI : 10.1128/AAC.00630-11

P. Miotto, A. M. Cabibbe, and S. Feuerriegel, Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study, mBio, vol.5, issue.5, pp.1819-01814, 2014.
DOI : 10.1128/mBio.01819-14

S. O. Simons, T. Van-der-laan, and A. Mulder, Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm, Clinical Microbiology and Infection, vol.20, issue.10, pp.1015-1020, 2014.
DOI : 10.1111/1469-0691.12696

Y. Zhang and D. Mitchison, The curious characteristics of pyrazinamide: a review, Int J Tuberc Lung Dis, vol.7, pp.6-21, 2003.

J. H. Choi, K. W. Lee, and H. R. Kang, Clinical Efficacy of Direct DNA Sequencing Analysis on Sputum Specimens for Early Detection of Drug-Resistant Mycobacterium tuberculosis in a Clinical Setting, Chest, vol.137, issue.2, pp.393-400, 2010.
DOI : 10.1378/chest.09-0150

E. M. Streicher, K. Maharaj, and T. York, Rapid Sequencing of the Mycobacterium tuberculosis pncA Gene for Detection of Pyrazinamide Susceptibility, Journal of Clinical Microbiology, vol.52, issue.11, pp.4056-4057, 2014.
DOI : 10.1128/JCM.02438-14

C. Surcouf, S. Heng, and C. Pierre-audigier, Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes, BMC Infectious Diseases, vol.22, issue.6, p.255, 2011.
DOI : 10.1007/s10096-003-0944-0
URL : https://hal.archives-ouvertes.fr/pasteur-00634125

F. Minime-lingoupou, C. Pierre-audigier, and E. Kassa-kelembho, Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic, Int J Tuberc Lung Dis, vol.14, pp.782-785, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00540451

C. Pierre-audigier, C. Surcouf, and V. Cadet-daniel, Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis [Short communication], The International Journal of Tuberculosis and Lung Disease, vol.16, issue.2, pp.221-223, 2012.
DOI : 10.5588/ijtld.11.0266

Z. Baharoglu and D. Mazel, Vibrio cholerae Triggers SOS and Mutagenesis in Response to a Wide Range of Antibiotics: a Route towards Multiresistance, Antimicrobial Agents and Chemotherapy, vol.55, issue.5, pp.2438-2441, 2011.
DOI : 10.1128/AAC.01549-10
URL : https://hal.archives-ouvertes.fr/pasteur-01423615

S. H. Gillespie, S. Basu, A. L. Dickens, O. Sullivan, D. M. Mchugh et al., Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates, Journal of Antimicrobial Chemotherapy, vol.56, issue.2, pp.344-348, 2005.
DOI : 10.1093/jac/dki191

E. Leporc, N. Carré, and S. Vandentorren, E ´ volution de la tuberculose en?Ileen? en?Ile-de-France de, Bull Epidémiol Hebd, vol.8, pp.138-143, 2014.

P. Xu, X. Li, and M. Zhao, Prevalence of Fluoroquinolone Resistance among Tuberculosis Patients in Shanghai, China, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.3170-3172, 2009.
DOI : 10.1128/AAC.00177-09

V. Crudu, E. Stratan, E. Romancenco, V. Allerheiligen, A. Hillemann et al., First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances, Journal of Clinical Microbiology, vol.50, issue.4, pp.1264-1269, 2012.
DOI : 10.1128/JCM.05903-11

X. Chen, F. Kong, Q. Wang, C. Li, J. Zhang et al., Rapid Detection of Isoniazid, Rifampin, and Ofloxacin Resistance in Mycobacterium tuberculosis Clinical Isolates Using High-Resolution Melting Analysis, Journal of Clinical Microbiology, vol.49, issue.10, pp.3450-3457, 2011.
DOI : 10.1128/JCM.01068-11

J. Kamerbeek, L. Schouls, and A. Kolk, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, vol.35, pp.907-914, 1997.

S. Sreevatsan, X. Pan, Y. Zhang, B. N. Kreiswirth, and J. Musser, Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms, Antimicrob Agents Chemother, vol.41, pp.636-640, 1997.

P. Escalante, S. Ramaswamy, and H. Sanabria, Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru, Tubercle and Lung Disease, vol.79, issue.2, pp.111-118, 1998.
DOI : 10.1054/tuld.1998.0013

M. Mestdagh, P. A. Fonteyne, and L. Realini, Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrugresistant clinical isolates of Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.43, pp.2317-2319, 1999.

H. J. Marttila, M. Marjamaki, and E. Vyshnevskaya, pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia, Antimicrob Agents Chemother, vol.43, pp.1764-1766, 1999.

S. J. Cheng, L. Thibert, T. Sanchez, L. Heifets, and Y. Zhang, pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis: Spread of a Monoresistant Strain in Quebec, Canada, Antimicrobial Agents and Chemotherapy, vol.44, issue.3, pp.528-532, 2000.
DOI : 10.1128/AAC.44.3.528-532.2000

K. W. Lee, J. M. Lee, and K. Jung, in Korea, Journal of Korean Medical Science, vol.16, issue.5, pp.537-543, 2001.
DOI : 10.3346/jkms.2001.16.5.537
URL : https://hal.archives-ouvertes.fr/hal-00882896

S. K. Park, J. Y. Lee, and C. L. Chang, pncA mutations in clinical Mycobacterium tuberculosisisolates from Korea, BMC Infectious Diseases, vol.79, issue.1, p.4, 2001.
DOI : 10.1054/tuld.1998.0013

M. M. Wade, D. Volokhov, M. Peredelchuk, V. Chizhikov, and Y. Zhang, Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray, Diagnostic Microbiology and Infectious Disease, vol.49, issue.2, pp.89-97, 2004.
DOI : 10.1016/j.diagmicrobio.2004.01.001

I. Portugal, L. Barreiro, J. Moniz-pereira, and L. Brum, pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates in Portugal, Antimicrobial Agents and Chemotherapy, vol.48, issue.7, pp.2736-2738, 2004.
DOI : 10.1128/AAC.48.7.2736-2738.2004

P. Jureen, J. Werngren, J. C. Toro, and S. Hoffner, Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.52, issue.5, pp.1852-1854, 2008.
DOI : 10.1128/AAC.00110-08

J. Jonmalung, T. Prammananan, M. Leechawengwongs, A. Chaiprasert, B. Oberhauser et al., Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand, BMC Microbiology, vol.10, issue.1, pp.223-90, 2010.
DOI : 10.1186/1471-2180-10-223

K. Hirano, M. Takahashi, Y. Kazumi, Y. Fukasawa, and C. Abe, Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis, Tubercle and Lung Disease, vol.78, issue.2, pp.117-122, 1998.
DOI : 10.1016/S0962-8479(98)80004-X

P. Barco, R. F. Cardoso, and R. D. Hirata, pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil, Journal of Antimicrobial Chemotherapy, vol.58, issue.5, pp.930-935, 2006.
DOI : 10.1093/jac/dkl363

A. Somoskovi, J. Dormandy, and L. M. Parsons, Sequencing of the pncA Gene in Members of the Mycobacterium tuberculosis Complex Has Important Diagnostic Applications: Identification of a Species-Specific pncA Mutation in "Mycobacterium canettii" and the Reliable and Rapid Predictor of Pyrazinamide Resistance, Journal of Clinical Microbiology, vol.45, issue.2, pp.595-599, 2007.
DOI : 10.1128/JCM.01454-06

P. Sheen, M. Mendez, and R. H. Gilman, Sputum PCR-singlestrand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients

C. Piersimoni, A. Mustazzolu, F. Giannoni, S. Bornigia, G. Gherardi et al., Prevention of False Resistance Results Obtained in Testing the Susceptibility of Mycobacterium tuberculosis to Pyrazinamide with the Bactec MGIT 960 System Using a Reduced Inoculum, Journal of Clinical Microbiology, vol.51, issue.1, pp.291-294, 2013.
DOI : 10.1128/JCM.01838-12

T. J. Tansel, O. French, and G. L. , Simultaneous identification and typing of multi-drug-resistant Mycobacterium tuberculosis isolates by analysis of pncA and rpoB, J Med Microbiol, vol.49, pp.651-656, 2000.

M. Mphahlele, H. Syre, and H. Valvatne, Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates, Journal of Clinical Microbiology, vol.46, issue.10, pp.3459-3464, 2008.
DOI : 10.1128/JCM.00973-08

M. T. Mccammon, J. S. Gillette, and D. P. Thomas, Detection by Denaturing Gradient Gel Electrophoresis of pncA Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from the United States-Mexico Border Region, Antimicrobial Agents and Chemotherapy, vol.49, issue.6, pp.2210-2217, 2005.
DOI : 10.1128/AAC.49.6.2210-2217.2005

G. E. Louw, R. M. Warren, and P. R. Donald, Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients, Int J Tuberc Lung Dis, vol.10, pp.802-807, 2006.

K. Stoffels, V. Mathys, M. Fauville-dufaux, R. Wintjens, and P. Bifani, Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.56, issue.10, pp.5186-5193, 2012.
DOI : 10.1128/AAC.05385-11

B. Cuevas-cordoba, S. O. Xochihua-gonzalez, A. Cuellar, J. Fuentes-dominguez, and R. Zenteno-cuevas, Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico, Infection, Genetics and Evolution, vol.19, pp.330-334, 2013.
DOI : 10.1016/j.meegid.2012.12.013

G. P. Morlock, J. T. Crawford, and W. R. Butler, Phenotypic Characterization of pncA Mutants of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.44, issue.9, pp.2291-2295, 2000.
DOI : 10.1128/AAC.44.9.2291-2295.2000

T. Tracevska, I. Jansone, V. Baumanis, A. Nodieva, O. Marga et al., Spectrum of pncA Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates Obtained in Latvia, Antimicrobial Agents and Chemotherapy, vol.48, issue.8, pp.3209-3210, 2004.
DOI : 10.1128/AAC.48.8.3209-3210.2004

F. Vde, M. A. Telles, M. O. Ribeiro, P. I. Cafrune, M. L. Rossetti et al., Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil, Antimicrob Agents Chemother, vol.49, pp.444-446, 2005.

J. Perdigao, R. Macedo, J. I. Fernandes, E. Brum, L. Portugal et al., Multidrug-Resistant Tuberculosis in Lisbon, Portugal: A Molecular Epidemiological Perspective, Microbial Drug Resistance, vol.14, issue.2, pp.133-143, 2008.
DOI : 10.1089/mdr.2008.0798

A. Martin, A. Groll, K. Fissette, J. C. Palomino, F. Varaine et al., Rapid Detection of Mycobacterium tuberculosis Resistance to Second-Line Drugs by Use of the Manual Mycobacterium Growth Indicator Tube System, Journal of Clinical Microbiology, vol.46, issue.12, pp.3952-3956, 2008.
DOI : 10.1128/JCM.01171-08

S. O. Simons, J. Van-ingen, and T. Van-der-laan, Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide, Journal of Clinical Microbiology, vol.50, issue.2, pp.428-434, 2012.
DOI : 10.1128/JCM.05435-11

S. Bhuju, F. Lde, S. Marsico, and A. G. , Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene, Infection, Genetics and Evolution, vol.19, pp.1-6, 2013.
DOI : 10.1016/j.meegid.2013.06.008

Y. Tan, Z. Hu, and T. Zhang, Role of pncA and rpsA Gene Sequencing in Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from Southern China, Journal of Clinical Microbiology, vol.52, issue.1, pp.291-297, 2014.
DOI : 10.1128/JCM.01903-13

A. Napiorkowska, R. ¨-usch-gerdes, S. Hillemann, D. Richter, E. Augustynowicz-kopec et al., Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany, The International Journal of Tuberculosis and Lung Disease, vol.18, issue.4, pp.454-460, 2014.
DOI : 10.5588/ijtld.13.0457

A. S. Lee, L. L. Tang, I. H. Lim, and S. Wong, Characterization of pyrazinamide and ofloxacin resistance among drug-resistant Mycobacterium tuberculosis isolates from Singapore, International Journal of Infectious Diseases, vol.6, issue.1, pp.48-51, 2002.
DOI : 10.1016/S1201-9712(02)90136-0

T. S. Huang, S. S. Lee, and H. Z. Tu, Correlation between Pyrazinamide Activity and pncA Mutations in Mycobacterium tuberculosis Isolates in Taiwan, Antimicrobial Agents and Chemotherapy, vol.47, issue.11, pp.3672-3673, 2003.
DOI : 10.1128/AAC.47.11.3672-3673.2003

A. Martin, H. Takiff, P. Vandamme, J. Swings, J. C. Palomino et al., A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide, Journal of Antimicrobial Chemotherapy, vol.58, issue.2, pp.327-331, 2006.
DOI : 10.1093/jac/dkl231

S. Hoffner, K. Angeby, and E. Sturegard, Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience, The International Journal of Tuberculosis and Lung Disease, vol.17, issue.11, pp.1486-1490, 2013.
DOI : 10.5588/ijtld.13.0195

J. H. Yoon, J. S. Nam, K. J. Kim, and Y. Ro, Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity, World Journal of Microbiology and Biotechnology, vol.10, issue.11, pp.2821-2828, 2014.
DOI : 10.1007/s11274-014-1706-0

N. Lemaitre, W. Sougakoff, C. Truffot-pernot, and V. Jarlier, Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase pncA, Antimicrob Agents Chemother, vol.43, pp.1761-1763, 1999.

A. Martin, A. Cubillos-ruiz, V. Groll, A. , D. Portillo et al., Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide, Journal of Antimicrobial Chemotherapy, vol.61, issue.1, pp.123-127, 2008.
DOI : 10.1093/jac/dkm418

Y. Suzuki, A. Suzuki, A. Tamaru, C. Katsukawa, and H. Oda, Rapid Detection of Pyrazinamide-Resistant Mycobacterium tuberculosis by a PCR-Based In Vitro System, Journal of Clinical Microbiology, vol.40, issue.2, pp.501-507, 2002.
DOI : 10.1128/JCM.40.2.501-507.2002

L. T. Daum, J. D. Rodriguez, and S. A. Worthy, Next-Generation Ion Torrent Sequencing of Drug Resistance Mutations in Mycobacterium tuberculosis Strains, Journal of Clinical Microbiology, vol.50, issue.12, pp.3831-3837, 2012.
DOI : 10.1128/JCM.01893-12

A. Scorpio, P. Lindholm-levy, and L. Heifets, Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.41, pp.540-543, 1997.

H. N. Jnawali, S. C. Hwang, and Y. K. Park, Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea, Diagnostic Microbiology and Infectious Disease, vol.76, issue.2, pp.187-196, 2013.
DOI : 10.1016/j.diagmicrobio.2013.02.035